These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 18506159)

  • 21. Newer therapeutic approaches to the vasculitides: biologic agents.
    Samuels J; Spiera R
    Rheum Dis Clin North Am; 2006 Feb; 32(1):187-200, xi. PubMed ID: 16504830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vasculitis syndrome].
    Yamada H; Ozaki S
    Nihon Rinsho; 2009 Mar; 67(3):507-10. PubMed ID: 19280924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Necrotizing vasculitis--a 2009 update.
    Sharaf PH; Yazici Y
    Bull NYU Hosp Jt Dis; 2009; 67(3):303-5. PubMed ID: 19852754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Refractory Takayasu arteritis successfully treated with infliximab.
    Maffei S; Di Renzo M; Santoro S; Puccetti L; Pasqui AL
    Eur Rev Med Pharmacol Sci; 2009; 13(1):63-5. PubMed ID: 19364087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Refractory Takayasu's arteritis successfully treated with the human, monoclonal anti-tumor necrosis factor antibody adalimumab.
    Tatò F; Rieger J; Hoffmann U
    Int Angiol; 2005 Sep; 24(3):304-7. PubMed ID: 16158044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Biological treatment of rare inflammatory rheumatic diseases].
    Baslund B
    Ugeskr Laeger; 2008 Jun; 170(24):2150-2. PubMed ID: 18565301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunosuppressive therapy of vasculitis: current aspects and perspectives].
    Giacomelli R; Pizzuto F; Cucinelli F; Tonietti G
    Recenti Prog Med; 1996 Mar; 87(3):124-34. PubMed ID: 8650433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of long-standing neuro-Behçet's disease with infliximab.
    Sarwar H; McGrath H; Espinoza LR
    J Rheumatol; 2005 Jan; 32(1):181-3. PubMed ID: 15630746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sarcoidosis, role of tumor necrosis factor inhibitors and other biologic agents, past, present, and future concepts.
    Sweiss NJ; Curran J; Baughman RP
    Clin Dermatol; 2007; 25(3):341-6. PubMed ID: 17560312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A patient with neuro-Behçet's disease is successfully treated with etanercept: further evidence for the value of TNFalpha blockade.
    Alty JE; Monaghan TM; Bamford JM
    Clin Neurol Neurosurg; 2007 Apr; 109(3):279-81. PubMed ID: 17174468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anatomopathology of inflammatory arteriopathies. Peculiar aspects of giant cell arteritis].
    Chomette G; Auriol M; Tranbaloc P
    Ann Med Interne (Paris); 1983; 134(5):421-7. PubMed ID: 6139972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-tumour necrosis factor-alpha therapy in heart failure: future directions.
    Balakumar P; Singh M
    Basic Clin Pharmacol Toxicol; 2006 Dec; 99(6):391-7. PubMed ID: 17169118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of TNF-α in a murine model of Kawasaki disease arteritis induced with a Candida albicans cell wall polysaccharide.
    Oharaseki T; Yokouchi Y; Yamada H; Mamada H; Muto S; Sadamoto K; Miura N; Ohno N; Saji T; Naoe S; Takahashi K
    Mod Rheumatol; 2014 Jan; 24(1):120-8. PubMed ID: 24261768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic update in large vessel vasculitides.
    Pérez-Esteban S; González-Gay MA; Castañeda S
    Rev Clin Esp (Barc); 2013 Oct; 213(7):338-46. PubMed ID: 23683962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Giant cell and Takayasu arteritis.
    Seko Y
    Curr Opin Rheumatol; 2007 Jan; 19(1):39-43. PubMed ID: 17143094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment and outcomes of large vessel arteritis.
    Borg FA; Dasgupta B
    Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):325-37. PubMed ID: 19508941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis.
    Taylor SR; Salama AD; Joshi L; Pusey CD; Lightman SL
    Arthritis Rheum; 2009 May; 60(5):1540-7. PubMed ID: 19404964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A brief history of Wegener's granulomatosis: on limited, localized, and generalized forms of the disease: comment on the article by the Wegener's Granulomatosis Etanercept Trial Research Group.
    Lamprecht P; Gross WL
    Arthritis Rheum; 2004 Jan; 50(1):334-5; author reply 335-6. PubMed ID: 14730635
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapy of neurological disorders in systemic vasculitis.
    Gold R; Fontana A; Zierz S
    Semin Neurol; 2003 Jun; 23(2):207-14. PubMed ID: 12894386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasculitis in the geriatric population.
    Langford CA
    Rheum Dis Clin North Am; 2007 Feb; 33(1):177-95. PubMed ID: 17367699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.